Literature DB >> 6793220

The effect of PCO2 on hypoxic pulmonary vasoconstriction.

W H Noble, J C Kay, J A Fisher.   

Abstract

Lung areas with a low V/Q ratio cause hypoxaemia. The low alveolar oxygen concentration may cause local hypoxic pulmonary vasoconstriction (HPV) which reduces perfusion, raises the V/Q ratio, and hence reduces the tendency to a low PaO2. By changing PCO2, the HPV response can be altered. We examined this relationship in anaesthetized dogs by using a tracheal divider to separate hypoxic (nitrogen ventilated) from oxygenated (100 per cent oxygen ventilated) lung. Relative perfusion was assessed from total 133Xe exhaled from each lung area after intravenous infusions. When PaCO2 was changed by changing ventilation, we found that an increasing PaCO2 increased HPV and also PaO2. At a PaCO2 of 3.3 kPa, HPV was abolished and PaO2 fell. We also changed PaCO2 by altering PICO2 to one or both lung areas while ventilation remained constant throughout the experiment. Again as PaCO2 increased, HPV and PaCO2 increased. When PaCO2 fell and end tidal carbon dioxide in the hypoxic lung (PETCO2) remained elevated by maintaining PICO2 in the hypoxic lung and removing CO2 from the oxygenated lung) HPV was maintained. Thus it is the alveolar concentration of CO2 in the hypoxic lung which is important in modifying HPV. We conclude that in this model a low PETCO2 (3.3 kPa) in hypoxic lung will reduce HPV, and will result in more severe hypoxaemia. This may have relevance in both anaesthetized and intensive care unit patients when a higher PaO2 may be obtained by increasing hypoxic lung PETCO2. The effect of PETCO2 on PaO2 will be influenced by other variables, but when hypoventilated or hypoxic exist, increasing PETCO2 may reinforce hypoxic pulmonary vasoconstriction and thus may increase PaO2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793220     DOI: 10.1007/BF03010350

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  18 in total

1.  KR85 IN THE STUDY OF PULMONARY CIRCULATION DURING BRONCHOSPIROMETRY.

Authors:  M ARBORELIUS
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

2.  Strength of pulmonary vascular response to regional alveolar hypoxia.

Authors:  C A Hales; B Ahluwalia; H Kazemi
Journal:  J Appl Physiol       Date:  1975-06       Impact factor: 3.531

3.  Hypoxia-induced pulmonary vasoconstriction in man: inhibition due to diethyl ether and halothane anesthesia.

Authors:  L J Bjertnaes
Journal:  Acta Anaesthesiol Scand       Date:  1978       Impact factor: 2.105

4.  Reduction of hypoxic pulmonary vasoconstriction in the dog during administration of nitrous oxide.

Authors:  M K Sykes; J B Hurtig; A R Tait; M K Chakrabarti
Journal:  Br J Anaesth       Date:  1977-04       Impact factor: 9.166

5.  Evaluation of a new method for the continuous measurement of the distribution of the blood flow between the two lungs.

Authors:  M K Sykes; A E Hill; L Loh; A R Tait
Journal:  Br J Anaesth       Date:  1977-04       Impact factor: 9.166

6.  Cardiac catheterization in dogs.

Authors:  W H Noble; J C Kay
Journal:  Can Anaesth Soc J       Date:  1974-11

7.  The effect of inhalational anaesthetics on hypoxic pulmonary vasoconstriction and pulmonary vascular resistance in the perfused lungs of the dog and cat.

Authors:  M K Sykes; L Loh; R F Seed; E R Kafer; M K Chakrabarti
Journal:  Br J Anaesth       Date:  1972-08       Impact factor: 9.166

8.  Influence of blood pH on hypoxic pulmonary vasoconstriction.

Authors:  T C Lloyd
Journal:  J Appl Physiol       Date:  1966-03       Impact factor: 3.531

9.  Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures.

Authors:  J L Benumof; E A Wahrenbrock
Journal:  J Appl Physiol       Date:  1975-05       Impact factor: 3.531

10.  Hypoxia-induced vasoconstriction in isolated perfused lungs exposed to injectable or inhalation anesthetics.

Authors:  L J Bjertnaes
Journal:  Acta Anaesthesiol Scand       Date:  1977       Impact factor: 2.105

View more
  6 in total

Review 1.  Is ventilator-induced lung injury a promoter of multiple organ failure in adult respiratory distress syndrome? The effect of permissive hypercapnia on oxygenation and outcome.

Authors:  Keith G Hickling
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

2.  Reply to Dorrington et al. and to Swenson: "Hypercapnic Pulmonary Vasoconstriction Contributes to Regional Perfusion Distribution: Relevance to Asthma" and "Hypercapnic Pulmonary Vasoconstriction as a Mechanism for Regional Perfusion Redistribution in Asthma".

Authors:  Vanessa J Kelly; Tilo Winkler; R Scott Harris
Journal:  Am J Respir Crit Care Med       Date:  2018-03-01       Impact factor: 21.405

3.  Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome.

Authors:  Armand Mekontso Dessap; Cyril Charron; Jérôme Devaquet; Jérôme Aboab; François Jardin; Laurent Brochard; Antoine Vieillard-Baron
Journal:  Intensive Care Med       Date:  2009-08-04       Impact factor: 17.440

4.  Variations in alveolar partial pressure for carbon dioxide and oxygen have additive not synergistic acute effects on human pulmonary vasoconstriction.

Authors:  Quentin P P Croft; Federico Formenti; Nick P Talbot; Daniel Lunn; Peter A Robbins; Keith L Dorrington
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

5.  Right ventriculo-arterial uncoupling and impaired contractile reserve in obese patients with unexplained exercise intolerance.

Authors:  Colm McCabe; Rudolf K F Oliveira; Farbod Rahaghi; Mariana Faria-Urbina; Luke Howard; Richard G Axell; Andrew N Priest; Aaron B Waxman; David M Systrom
Journal:  Eur J Appl Physiol       Date:  2018-04-30       Impact factor: 3.078

6.  Application of a novel in vivo imaging approach to measure pulmonary vascular responses in mice.

Authors:  Melissa Preissner; Rhiannon P Murrie; Catherine Bresee; Richard P Carnibella; Andreas Fouras; E Kenneth Weir; Stephen Dubsky; Isaac P Pinar; Heather D Jones
Journal:  Physiol Rep       Date:  2018-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.